Biobanking

Biobanking refers to the systematic collection, processing, storage, and management of biological specimens such as blood, tissue, cells, and nucleic acids for research and clinical applications. These stored specimens are linked to associated clinical or demographic data, enabling longitudinal studies and retrospective analyses that support biomarker discovery and precision medicine development. Biobanking operations require strict governance, traceability systems, and controlled storage conditions to maintain specimen integrity.

The biopharmaceutical industry uses biobanking extensively in clinical trials to support pharmacokinetic analyses, biomarker validation, and correlative studies linking biological signals with treatment outcomes. High quality biobanking enables robust translational research by allowing scientists to explore disease mechanisms and identify predictive markers of response or toxicity. Companies implement standardised procedures to minimise pre-analytical variability and ensure consistency across collection sites. Ethical considerations including informed consent, privacy protection, and controlled access remain central to biobanking governance, particularly as genomic analysis becomes increasingly integrated into drug development strategies.